Okada, M., Takeda, H., Sakaki, H., Kuramoto, K., Suzuki, S., Sanomachi, T., . . . Kitanaka, C. (2017). Repositioning CEP-1347, a chemical agent originally developed for the treatment of Parkinson’s disease, as an anti-cancer stem cell drug. Oncotarget.

Okada, Masashi, Hiroyuki Takeda, Hirotsugu Sakaki, Kenta Kuramoto, Shuhei Suzuki, Tomomi Sanomachi, Keita Togashi, Shizuka Seino, and Chifumi Kitanaka. "Repositioning CEP-1347, a Chemical Agent Originally Developed for the Treatment of Parkinson’s Disease, As an Anti-cancer Stem Cell Drug." Oncotarget 2017.

Okada, Masashi, et al. "Repositioning CEP-1347, a Chemical Agent Originally Developed for the Treatment of Parkinson’s Disease, As an Anti-cancer Stem Cell Drug." Oncotarget 2017.